Cormorant Asset Management

Hedge Fund SEC-registered adviser

Legal name: Cormorant Asset Management, LP

Boston, MA Website LinkedIn

AUM

$3.8B
Regulatory AUM

Private funds

7
Private Equity 6 · Hedge Fund 1

Private fund assets

$3.8B
Gross asset value

Employees

12

Last Form D raise

Jun 2026
Most recent fund filing

From SEC Form ADV filing (filed May 27, 2026). View on SEC

People(1)

Owners and executive officers named on the firm's SEC Form ADV.

B
Bihua Chen
Managing Member & Chief Executive Officer
Source: SEC Form ADV

Funds(7)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Cormorant Private Healthcare Fund VI, LPPrivate Equity$102.9M$175.6M56Jun 2026Hot
Cormorant Global Healthcare Master Fund, LPHedge Fund$2.2B$589.2M52Mar 2026Warm
Cormorant Private Healthcare Fund V, LPPrivate Equity$491.7M$318.0M56Aug 2024Cold
Cormorant Private Healthcare Fund IV, LPPrivate Equity$426.3M$69.2M7Aug 2021Cold
Cormorant Private Healthcare Fund III, LPPrivate Equity$429.5M$213.7M38Jun 2021Cold
Cormorant Private Healthcare Fund II, LPPrivate Equity$125.2M$93.2M14Aug 2018Cold
Cormorant Private Healthcare Fund I, LPPrivate Equity$49.8M——Feb 2016Cold

Board seats(2)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Graviton BioScience
BiotechnologyNew York, NYDirector: Bihua Chen
$93.3M raised
Since Dec 2023
SEC Form D
Apellis Pharmaceuticals
PharmaceuticalsCrestwood, KYDirector: Bihua Chen
$134.9M raised
Since Jan 2016
SEC Form D

Regulatory identifiers

CRD number
167820
SEC file number
801-79513
CIK
1583977

Sources